Lepodisiran

Lepodisiran is a small interfering RNA that was developed to reduce lipoprotein in people at risk of cardiovascular disease. It was developed by Eli Lilly and Company. Wikipedia

• Legal status:  Investigational
• CAS Number:  2808361-18-2
• ATC code:  ATC code
• UNII:  X4BE7S8PN9
• Synonyms:  LY3819469, LY-3819469
• Data source:  DuckDuckGo